Treating Patients with ECP from A–Z – The Nordic Approach - Advancing Knowledge on ECP Technology

Day 1 - 27 octubre 2025

Arrival of participants

19.00 – 19.30
Meeting in the lobby

19.30
Dinner 

Day 2 - 28 octubre 2025

09.00 – 09.10
Welcome and introduction - Therakos International Healthcare Stakeholders Engagement

09.10 - 10.00
Visit to treatment area - All

10.00 - 11.00
Department and ECP set-up - Jørn Kristiansen, Nurse

11.00 – 11.15
Group discussion

11.15 – 11.30
Coffee break

11.30 – 12.00
ECP treatment pathway – a patient perspective - Alf Johnson

12.00 - 12.30
Patient Focus and Nordic ECP Guidelines - Tobias Gedde-Dahl

12.30 - 13.00
ECP in acute and chronic GvHD – Oslo experience - Alba Pons

13.00 – 14.00
Lunch

14.00 - 14.45 
Nurses' role in ECP treatment - Alba Pons

14.45 – 15.45
Vascular Access - Daniel Wergeland

15.45 - 16.15
Managing patients - A cross-departmental approach - Daniel Wergeland

16.15 – 16.30
Group discussion

16.30 – 16.45
Final remarks and close - Daniel Wergeland

ECP: Extracorporeal Photopheresis, GvHD: Graft versus Host Disease

All speakers are subject to contract.
This is a commercial programme run by Therakos (UK) Ltd, part of Mallinckrodt Pharmaceuticals
This information is intended for healthcare professionals based in Europe and the Middle East.